• Large-scale behavioral characterization of oxycodone self-administration in heterogeneous stock rats reveals initial analgesic effects are associated with addiction-like behaviors
  Published on 2026-01-29
  8 months ago
• Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive disorders
  Published on 2026-01-29
  8 months ago
• The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders
  Published on 2026-01-27
  8 months ago
• The role of ovarian hormones in risk aversion in female rats
  Published on 2026-01-25
  8 months ago
• Nancy Almand Ator, Ph.D. 1944–2025
  Published on 2026-01-25
  8 months ago
• Clinical staging and profiling of affective disorders
  Published on 2026-01-23
  8 months ago
• Prolonged grief disorder in later life: advancing our understanding of biopsychosocial mechanisms to guide future personalized interventions
  Published on 2026-01-22
  8 months ago

« Previous 1 … 30 31 32 33 34 … 143 Next »

• Deaths related to the use of diarylethylamines, with a focus on the United Kingdom: A systematic review and case series report
  Published on 2025-07-01
  1 year ago
• Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression
  Published on 2025-07-01
  1 year ago
• Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review
  Published on 2025-06-30
  1 year ago
• Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder
  Published on 2025-06-28
  1 year ago
• OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
  Published on 2025-06-28
  1 year ago
• Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls – A randomized placebo-controlled crossover trial
  Published on 2025-06-27
  1 year ago
• Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
  Published on 2025-06-27
  1 year ago

« Previous 1 … 30 31 32 33 34 … 154 Next »

• Ketamine addiction in Europe: Any risks on the horizons?
  Published on 2025-03-10
  2 years ago
• Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis
  Published on 2025-03-09
  2 years ago
• Preclinical drug development: Seeking to improve the reproducibility of results from behavioural experiments in animals
  Published on 2025-03-09
  2 years ago
• Muscarinic acetylcholine receptor agonists in bipolar disorder
  Published on 2025-03-09
  2 years ago
• Extracellular vesicles in mood disorders: A systematic review of human studies
  Published on 2025-03-09
  2 years ago
• Muscle and the mind: The combination of creatine and exercise for depression
  Published on 2025-03-07
  2 years ago
• Sex differences in schizophrenia-related mortality: A call for targeted interventions
  Published on 2025-03-07
  2 years ago

« Previous 1 … 30 31 32 33 34 … 170 Next »